Wednesday, April 20, 2016

Big news on marijuana

The Drug Enforcement Agency will soon consider whether to reclassify marijuana and remove it from the Schedule 1 list. Tell the DEA to decriminalize marijuana and open it to medicinal research.

Dear MoveOn member,

The Drug Enforcement Administration just announced that they'll soon consider whether to reclassify marijuana and remove it from its Schedule 1 "dangerous drugs" category.1 Will you join me in calling to decriminalize marijuana? Click here to sign the petition to President Barack Obama, which says:

If the DEA doesn't act, issue an Executive Order to remove the Schedule 1 classification from marijuana and decriminalize this natural herb.

There are well over 100 scientific studies showing definitive benefits of medical marijuana pertaining to pain management, sleep management, anger management, anxiety disorders, seizures, cancer, and other ailments.2

Decriminalizing marijuana is the right thing to do, and it is necessary to do. We must end the destruction of hundreds of thousands of young lives by criminalizing them for possessing a harmless, natural substance.

Click here to add your name to this petition, and then pass it along to your friends.


—Eric Bruce Eichbauer


1. "DEA Plans To Decide Whether To Reschedule Marijuana By Mid-Year," The Huffington Post, April 5, 2016

2. "Emerging Clinical Applications For Cannabis and Cannabinoids: A Review of the Recent Scientific Literature," NORML, accessed April 18, 2016

You're receiving this petition because we thought it might interest you. It was created on, where anyone can start their own online petitions. You can start your own petition here.

Want to support our work? MoveOn member contributions have powered our work together for more than 17 years. Hundreds of thousands of people chip in each year—which is why we're able to be fiercely independent, answering to no individual, corporation, politician, or political party. You can become a monthly donor by clicking here, or chip in a one-time gift here.

No comments:

Post a Comment